Find Federal Grants
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-24-012
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-24-007
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-24-006
Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-22-512
Research Resource for Systematic Reviews of Complementary and Integrative Health (R24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AT-24-005
Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-22-513
Single Source: NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-EB-23-007
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
National Institutes of Health · PAR-23-220
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-219
Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-24-151
Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)
National Institutes of Health · RFA-MH-24-150
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
National Institutes of Health · PA-23-233
PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
National Institutes of Health · PA-23-232
PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
National Institutes of Health · PA-23-230
PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
National Institutes of Health · PA-23-231
Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
National Institutes of Health · PAR-23-216
Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
National Institutes of Health · RFA-RM-23-013
USAID Integrated Nutrition
Nepal USAID-Kathmandu · 72036723RFA00006
ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-23-018
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-ES-23-011